The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 13, 2024
Filed:
Jul. 22, 2019
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
James Aaron Balog, Princeton, NJ (US);
Jay A. Markwalder, Princeton, NJ (US);
Weifang Shan, Princeton, NJ (US);
David K. Williams, Princeton, NJ (US);
Susheel Jethanand Nara, Bangalore, IN;
Saumya Roy, Bangalore, IN;
Soodamani Thangavel, Bangalore, IN;
Srinivas Cheruku, Bangalore, IN;
Ramesh Kumar Sistla, Bangalore, IN;
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 31/4418 (2006.01); A61K 31/4439 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 39/395 (2006.01); C07D 213/74 (2006.01); C07D 213/75 (2006.01); C07D 401/14 (2006.01); C07D 403/10 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01); C07D 417/10 (2006.01); C07D 417/14 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/4418 (2013.01); A61K 31/4439 (2013.01); A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 39/3955 (2013.01); C07D 213/74 (2013.01); C07D 213/75 (2013.01); C07D 401/14 (2013.01); C07D 403/10 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01); C07D 417/10 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01);
Abstract
The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.